UMass Medical School pharmacy experts to present at American Drug Utilization symposium

February 23, 2015

Clinical pharmacists from UMass Medical School will discuss opiates and the management of Hepatitis C drugs in Massachusetts at the American Drug Utilization Review Society (ADURS) 2015 Symposium Feb. 26-28 at the DoubleTree Paradise Valley Resort in Scottsdale, Arizona.

All of the presenters are clinical pharmacists UMass Medical School’s Commonwealth Medicine division. Details of the presentations follow.

Implementation of a Pediatric Behavioral Health Medication Safety Initiative in a State Medicaid Program
The poster will address concerns about an increase in the use of behavioral medications in children and the need to manage prescribing practices to ensure appropriate use of the drugs.
Donna M. Faber, PharmD, BCPS, clinical consultant pharmacist
Payal N. Kotadiya, PharmD, BCPS, clinical consultant pharmacist
Kimberly Lenz, PharmD, clinical pharmacy manager, Office of Clinical Affairs
Amy L. Levy, MHP, BS, RPH, director of special projects
Paul L. Jeffrey, PharmD, pharmacy director, Office of Clinical Affairs

Friday, Feb. 27
One State's Perspective on the Management of Hepatitis C Drugs
9:10 to 10:10 a.m.
Pavel Lavitas, PharmD, BCPS, clinical consultant pharmacist

Saturday, Feb. 28
An Up-to-Date Review of the Treatment of Childhood Depression
9:40 to 10:40 a.m.
Michael C. Angelini, MA, PharmD, BCPS, behavioral health medicine consultant, and associate professor, Massachusetts College of Pharmacy and Health Sciences University
Risk and Benefit of the Concomitant Use of Benzodiazepines and Opiates
1:15 to 2:15 p.m.
Michael C. Angelini, MA, PharmD, BCPS, behavioral health medicine consultant, and associate professor, Massachusetts College of Pharmacy and Health Sciences University